These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
21. Different changes of plasma membrane beta-adrenoceptors in rat heart after chronic administration of propranolol, atenolol and bevantolol. Horinouchi T; Morishima S; Tanaka T; Suzuki F; Tanaka Y; Koike K; Miwa S; Muramatsu I Life Sci; 2007 Jul; 81(5):399-404. PubMed ID: 17628611 [TBL] [Abstract][Full Text] [Related]
22. Nylidrin: a potent anti-hypertensive agent in hypertensive rats. Yen TT; Pearson DV Res Commun Chem Pathol Pharmacol; 1979 Jan; 23(1):11-28. PubMed ID: 441505 [TBL] [Abstract][Full Text] [Related]
23. [Hypertensive activity of isoteolin]. Zheliazkov D; Markov M Eksp Med Morfol; 1984; 23(3):127-33. PubMed ID: 6549162 [No Abstract] [Full Text] [Related]
24. Comparison of hypotensive and hypolipidemic effects of Catharanthus roseus leaves extract with atenolol on adrenaline induced hypertensive rats. Ara N; Rashid M; Amran MS Pak J Pharm Sci; 2009 Jul; 22(3):267-71. PubMed ID: 19553172 [TBL] [Abstract][Full Text] [Related]
25. [Action mechanism of anti-hypertensive drugs, with special reference to beta blocking drugs]. Imai S Nihon Jinzo Gakkai Shi; 1975 Jul; 17(7):674-7. PubMed ID: 4637 [No Abstract] [Full Text] [Related]
26. Atenolol reduces blood pressure and FEV in normal subjects. Fuller RW; Vallance PJ Br J Clin Pharmacol; 1982 Sep; 14(3):445-6. PubMed ID: 7126417 [TBL] [Abstract][Full Text] [Related]
27. Impaired vasoconstrictor nerve function in spontaneously hypertensive rats after long-term treatment with propranolol and metroprolol. Ljung B; Ablad B; Dahlöf C; Henning M; Hultberg E Blood Vessels; 1975; 12(5):311-5. PubMed ID: 241443 [No Abstract] [Full Text] [Related]
28. Atenolol eye drops. Phillips CI; Macdonald M; Gore SM; Cullen PM Br Med J; 1976 Dec; 2(6049):1448. PubMed ID: 12855 [No Abstract] [Full Text] [Related]
29. Studies on the metabolism of atenolol. Characterization and determination of a new urinary metabolite in the rat. Matsuki Y; Ito T; Komatsu S; Nambara T Chem Pharm Bull (Tokyo); 1982 Jan; 30(1):196-201. PubMed ID: 7083403 [No Abstract] [Full Text] [Related]
30. Beta-adrenoceptor blocking drugs, heart rate and genetic hypertension development in rats. Richer C; Venturini-Souto N; Giudicelli JF Experientia; 1979 May; 35(5):656-7. PubMed ID: 36293 [TBL] [Abstract][Full Text] [Related]
31. [Anti-hypertensive action of tenormine in the genetically hypertensive rat]. Boissier JR; Giudicelli ; Richer C Nouv Presse Med; 1975 May; 4(22):1661. PubMed ID: 2904 [No Abstract] [Full Text] [Related]
32. Synergistic effects of atenolol and amlodipine for lowering and stabilizing blood pressure in 2K1C renovascular hypertensive rats. Shen FM; Xie HH; Ling G; Xu LP; Su DF Acta Pharmacol Sin; 2005 Nov; 26(11):1303-8. PubMed ID: 16225751 [TBL] [Abstract][Full Text] [Related]
33. beta-adrenoreceptor blocking and antihypertensive activity of PP-24, a newly synthesized aryloxypropanolamine derivative. Nikam AP; Bodhankar SL; Piplani P; Bansal J; Thakurdesai PA J Pharm Pharmacol; 2008 Nov; 60(11):1501-6. PubMed ID: 18957171 [TBL] [Abstract][Full Text] [Related]
34. Cardiovascular effects of tolamolol (UK-6558), a new beta-adrenoreceptor blocking drug, in pinealectomized hypertensive rats. Karppanen H; Lahovaara S; Mattila MJ Ann Med Exp Biol Fenn; 1973 Mar; 51(3):104-11. PubMed ID: 4149365 [No Abstract] [Full Text] [Related]
35. The demonstration of atenolol as a beta-adrenoceptor blocking drug in man. Harry JD Postgrad Med J; 1977; 53 Suppl 3():65-9. PubMed ID: 928268 [No Abstract] [Full Text] [Related]